Advertisement
Screener

HALOZYME THERAPEUTICS, INC. (HALO) Long-Term Debt, Maturity, Year One

2.8 / 5 stars · 68/120 Roast Me

HALOZYME THERAPEUTICS, INC. Long-Term Debt, Maturity, Year One

HALOZYME THERAPEUTICS, INC. (HALO) had Long-Term Debt, Maturity, Year One of $11.84 million as of 2025-12-31, per its 10-K filed 2026-02-17.

Financial Statements › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity

us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths · last filed 2026-02-17

  • 2025-12-31: Long-Term Debt, Maturity, Year One $11.84M.
  • 2024-12-31: Long-Term Debt, Maturity, Year One $9.21M.
  • 2023-12-31: Long-Term Debt, Maturity, Year One $9.21M.
  • 2022-12-31: Long-Term Debt, Maturity, Year One $22.75M.
Period endLong-Term Debt, Maturity, Year One
2025-12-31$11.84M
10-K · filed 2026-02-17
2024-12-31$9.21M
10-K · filed 2025-02-18
2023-12-31$9.21M
10-K · filed 2024-02-20
2022-12-31$22.75M
10-K · filed 2023-02-21
2021-12-31$94.08M
10-K · filed 2022-02-22
2020-12-31$465.75M
10-K · filed 2021-02-23
2019-12-31$26.10M
10-K · filed 2020-02-24
2018-12-31$100.17M
10-K · filed 2019-02-21
2017-12-31$94.13M
10-K · filed 2018-02-20
2016-12-31$37.34M
10-K · filed 2017-02-28
2015-12-31$25.08M
10-K · filed 2016-02-29
2014-12-31$3.77M
10-K · filed 2015-03-02
2013-12-31$3.46M
10-K · filed 2014-02-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
EXELIXIS, INC. (EXEL)United States$14.358B16.15
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Immunovant, Inc. (IMVT)United States$7.028B-14.78